Advertisement

What We’re Reading

“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.

(What’s a blog, you ask? It’s short for “weblog,” and you’re reading one right now! Learn more about blogs from our earlier post on the topic.)

This week, we’d like to direct your attention to this post at diabetes.about.com about Wal-Mart’s new generic drug program, which will offer month-long supplies of 314 of the most commonly prescribed generic drugs for $4.00 apiece. This blog is written by Debra Manzella, a writer and practicing nurse. Read More “What We’re Reading”

Public Warned About Fake OneTouch Test Strips

The U.S. Food and Drug Administration (FDA) is alerting people with diabetes to watch out for counterfeit blood glucose test strips intended for use with various models of LifeScan’s OneTouch blood glucose meters. While this announcement was originally made last Friday, October 13, additional lots of counterfeit test strips have been discovered over the past few days. Read More “Public Warned About Fake OneTouch Test Strips”

New Diabetes Drug Januvia Approved by FDA

The U.S. Food and Drug Administration (FDA) approved a new oral diabetes drug on Tuesday, October 17. The drug, sitagliptin (brand name Januvia), is manufactured by the pharmaceutical company Merck & Co., Inc., and is meant for use in people with Type 2 diabetes. Januvia is the first drug in a new class called dipeptidyl peptidase IV (or DPP-4) inhibitors to be approved. Read More “New Diabetes Drug Januvia Approved by FDA”

Accu-Chek Insulin Pump Hits U.S. Market

The Accu-Chek Spirit insulin pump, manufactured in Switzerland by Disetronic Medical Systems (a subsidiary of Roche Diagnostics Corp.), is now available in the United States. The pump “system,” which includes the Spirit insulin pump, a Palm PDA with Accu-Chek Pocket Compass software, a choice of one of three Accu-Chek blood glucose meters, and a choice of carrying case, will begin shipping on October 30. Read More “Accu-Chek Insulin Pump Hits U.S. Market”

Not Taking Prescribed Drugs Linked with Death in People with Diabetes

A recently published study of over 11,500 people with diabetes showed that a significant number—21%—do not take their blood-pressure–lowering, cholesterol-lowering, or blood-glucose–lowering pills regularly. Not surprisingly, the study found that these people have higher blood pressure, LDL (“bad”) cholesterol, and HbA1c levels (a measure of blood glucose over time). They also have a much higher chance of being hospitalized or dying than people who take their medicines regularly. Read More “Not Taking Prescribed Drugs Linked with Death in People with Diabetes”

Mixed Results in Islet Transplantation Study

For years, the transplantation of insulin-producing pancreatic islet cells has held promise as a potential cure for Type 1 diabetes. Now, a new study has shown that while transplantation can help recipients improve their blood glucose control, the transplanted cells tend to lose function progressively, requiring most recipients to resume insulin injections within two years. Read More “Mixed Results in Islet Transplantation Study”

Flu Shot Especially Important for People with Cardiovascular Disease

Believe it or not, flu season is approaching, and it’s not too early to start thinking about getting your annual vaccination. The American Heart Association and the American College of Cardiology are advising all people with cardiovascular disease to get a flu shot because their risk of dying from influenza (“the flu”) is higher than that of any other group. Cardiovascular disease (which includes heart disease and stroke) is the most common long-term complication of diabetes. Read More “Flu Shot Especially Important for People with Cardiovascular Disease”

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites